Status: current, Defined. Date: 28-Feb 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3227381000168113 | chondroitin sulfate + hyaluronate sodium (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3227391000168111 | chondroitin sulfate + hyaluronate sodium | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| chondroitin sulfate + hyaluronate sodium | Is a | hyaluronate sodium | true | Inferred relationship | Some | ||
| chondroitin sulfate + hyaluronate sodium | has intended active ingredient | chondroitin sulfate | true | Inferred relationship | Some | 2 | |
| chondroitin sulfate + hyaluronate sodium | has intended active ingredient | hyaluronate sodium | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Is a | False | chondroitin sulfate + hyaluronate sodium | Inferred relationship | Some | |
| sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe | Is a | True | chondroitin sulfate + hyaluronate sodium | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR